111, Inc. Deepens Partnership with Bayer Healthcare


111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced the expansion of its existing partnership with Bayer Healthcare Co. Ltd. (“Bayer”).

111 and Bayer Healthcare first entered into a strategic partnership in September 2020, to collaborate on drug commercialization initiatives in China. Specifically, 111 and Bayer agreed to work towards the commercialization of innovative drugs and healthcare products for chronic disease management, as well as providing useful resources for patient education. Leveraging 111’s vast network of pharmacies and healthcare providers facilitates the expansion of Bayer’s presence in underserved markets in China, as well as enhances the leading drug maker’s channel management and patient outreach capabilities. The two companies also agreed to jointly develop a digital content portal that provides online pharmacist training, as well as interactive patient education, and other services. The goal of this platform is to allow patients, healthcare providers, and pharmaceutical companies to work together to create patient-centric healthcare management plans that focus on providing quality service, in a more convenient and less restrictive way for the patient.

Read More

Next Post

Evive Awarded Patent for Healthcare Recommendation and Prediction System

Evive, the leader in digital engagement and communication technology, today announced they have been awarded a patent for their Healthcare Recommendation and Prediction System by the United States Patent and Trademark Office. In preparation for the upcoming healthcare transparency regulations (Transparency in Coverage Final Rule) included in the 2021 Consolidated […]